Galderma

Galderma
Subsidiary of Nestlé
Industry Dermatology
Pharmaceuticals
Founded 1981
Founder M. Owen
Headquarters Galderma Pharma SA/Galderma SA Lausanne, Switzerland
Revenue €1.7 billion in 2013
Number of employees
 +5,000
Website www.galderma.com

Galderma S.A. is a pharmaceutical subsidiary specializing in the research, development and marketing of dermatological treatments and became a wholly owned subsidiary of Nestlé in 2014.

About

Galderma was formed in 1981 as a joint venture between Nestlé and L'Oréal.[1] The company, headed by President & CEO Humberto C. Antunes, has 33 affiliates in 100 countries[2] with a worldwide network of distributors and employs more than 5,000 people. The parent company is based in Lausanne, Switzerland, with Corporate Services in Paris-La Défense, France.

The Galderma Code of Ethics[3] lists all applicable legal requirements in the countries where Galderma operates. Galderma S.A. have extensive policies and procedures contained in other supporting documents.[4] talking in terms of environment, social aspects and business ethics..

History

The origins of Galderma date back to 1961 and the founding of the Owen dermatology company in Dallas, Texas, USA by M. Owen.

In 2007, the Galderma Global Corporate Campaign won the Medical Marketing Association's International Award of Excellence.

In 2010, sales reached 1.2 billion euros, an increase of 16.1% over 2009.

In 2011, Galderma acquired Q-Med, a Swedish medical-device company.[5]

In 2014, Nestlé buys back all the shares from L'Oréal, thus creating a new unit into Nestlé group called: "Nestle Skin Health". The transaction has a value of €3.1 billion, (USD$4.23 billion), was paid by Nestlé with 21.2 million L'Oréal shares.[6] L'Oréal will pay €3.4 billion (USD$4.63 billion) for the remaining 27.3 million shares.[6]

Activities

Galderma provides a range of products used to treat acne, rosacea, psoriasis and other steroid-responsive dermatoses (SRD), onychomycosis (fungal nail infections), pigmentary disorders, skin cancer and skin senescence. Galderma’s products sell in more than 70 countries.

The company invests substantially in research and development and sources new treatments from its own activities and from its partnerships with others. It divides its research and development departments between four sites:

Galderma has manufacturing facilities at the following locations:

The French and Canadian plants have grown in order to improve and increase production capacity. As of 2011 the four sites combined produced over 100 million units.

Notes and references

  1. ↑ Nestlè
  2. ↑ "Dermatology company". Galderma. Retrieved 2012-06-10.
  3. ↑ "Galderma Code Of Ethics". Retrieved 2013-02-27.
  4. ↑ "Galderma Supplier Code". Retrieved 2013-02-27.
  5. ↑ "Nestlè Financial Statement 2012" (PDF). Galderma. Retrieved 2013-02-26.
  6. 1 2 Socha, Miles (11 February 2014). "L'Oréal to Buy 8% of Share Capital From Nestlé". WWD. Retrieved 11 February 2014.

See also


This article is issued from Wikipedia - version of the 11/21/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.